Provided by Tiger Fintech (Singapore) Pte. Ltd.

Indaptus Therapeutics, Inc.

2.27
-0.3100-12.02%
Volume:34.05K
Turnover:82.72K
Market Cap:3.98M
PE:-0.06
High:2.64
Open:2.64
Low:2.25
Close:2.58
52wk High:47.60
52wk Low:2.22
Shares:1.75M
Float Shares:850.70K
Volume Ratio:0.85
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-37.5059
EPS(LYR):-44.9582
ROE:-317.98%
ROA:-131.38%
PB:0.86
PE(LYR):-0.05

Loading ...

Feb 12, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Dec 30, 2024

Correspondence

Form CORRESP - Correspondence
Dec 23, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 18, 2024

Correspondence

Form CORRESP - Correspondence
Sep 12, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report